%D8%AC%D9%8A%D9%85%D8%B3%D9%8A%D8%AA%D8%A7%D8%A8%D9%8A%D9%86%D8%AC%D9%85%D8%B3%DB%8C%D8%AA%D8%A7%D8%A8%DB%8C%D9%86Category:GemcitabineGemcitabinGemcitabin%CE%93%CE%B5%C2%B5%CF%83%CE%B9%CF%84%CE%B1%CE%B2%CE%AF%CE%BD%CE%B7GemcitabineGemcitabinaGemzitabina%D8%AC%D9%85%D8%B3%DB%8C%D8%AA%D8%A7%D8%A8%DB%8C%D9%86GemsitabiiniGemcitabine%D4%B3%D5%A5%D5%B4%D6%81%D5%AB%D5%BF%D5%A1%D5%A2%D5%AB%D5%B6GemsitabinGemcitabina%E3%82%B2%E3%83%A0%E3%82%B7%E3%82%BF%E3%83%93%E3%83%B3%E0%AC%9C%E0%AD%87%E0%AC%AE%E0%AC%B8%E0%AC%BE%E0%AC%87%E0%AC%9F%E0%AC%BE%E0%AC%AC%E0%AC%BF%E0%AC%A8GemcytabinaGemcitabinaGemcitabin%C4%83%D0%93%D0%B5%D0%BC%D1%86%D0%B8%D1%82%D0%B0%D0%B1%D0%B8%D0%BDGemcitabinGemcitabinGemcitabin%D0%93%D0%B5%D0%BC%D1%86%D0%B8%D1%82%D0%B0%D0%B1%D1%96%D0%BDGemcitabineQ414143%E5%90%89%E8%A5%BF%E4%BB%96%E6%BB%A8
about
non-Hodgkin lymphomainvasive mammary ductal carcinomasquamous cell carcinoma of the lunghead and neck squamous cell carcinomamature T-cell and NK-cell lymphomagerm cell cancerbladder urothelial carcinomapancreatic adenocarcinomabile duct carcinomauterus leiomyosarcomacribriform carcinomamycosis fungoideslymphomatransitional cell carcinomadiffuse large B-cell lymphomatongue squamous cell carcinomanon-small-cell lung carcinomabladder cancercarcinoma of gallbladder and extrahepatic biliary tractbone sarcomapancreatic ductal adenocarcinoma
P2176
P3781
A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the PancreasDurvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract CancerA Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsGEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract CancerOral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract CancerEvaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node MetastasisVinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic CancerS-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic CancerSurvival imProvement in Lung cancEr iNduced by DenOsUmab theRapyStudy of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of CholangiocarcinomaSIMPLE Chemotherapy for NK Lymphoma/LeukaemiaGemcitabine and Nabpaclitaxel in Metastatic Pancreatic Carcinoma.PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal CarcinomaPhase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin LymphomaThe Efficacy of Bendamustine, Gemcytabine, Dexamethasone (BGD) Salvage Chemotherapy With Autologous Stem Cell Transplantation (ASCT) Consolidation in Advanced Classical Hodgkin Lymphoma Patients Not Responding to ABVD TherapyTrastuzumab in HER2-positive Biliary Tract CancerAcelarin First Line Randomised Pancreatic StudyA Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesNab-Paclitaxel and Durvalumab With or Without Neoantigen Vaccine in Treating Patients With Metastatic Triple Negative Breast CancerChidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin LymphomaFolfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic CancerGemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory OsteosarcomaStudy of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell LymphomaStudy of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial CancerRandomized Controlled Trial of Gemcitabine Combined With 125I BrachytherapyA Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic CancerAntiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic CancerA Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic CancerOxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic CancerA Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's LymphomaMethotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder CancerGemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryGemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With IrinotecanCapecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell CarcinomaClinical Trial on the Mixture of G, C and S in Treatment of Patients With RCCPhase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC
P4844
Mechanism of Activation of -D-2'-Deoxy-2'-Fluoro-2'-C-Methylcytidine and Inhibition of Hepatitis C Virus NS5B RNA PolymeraseGemcitabine-related radiation recall in a patient with pancreatic cancerRole of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitroTumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionIrinotecan in combined-modality therapy for locally advanced non-small-cell lung cancer.Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors.Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction.Paclitaxel and carboplatin in combination with gemcitabine: a phase I-II trial in patients with advanced non-small-cell lung cancer. Gruppo Studio Tumori Polmonari Veneto (GSTPV).Gemcitabine and carboplatin for patients with advanced non-small cell lung cancer.Phase II trial of gemcitabine in advanced sarcomas.Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.Prolonged infusion of gemcitabine in advanced solid tumors: a phase-I-study.Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study.Gemcitabine, irinotecan and celecoxib in patients with biliary cancer.The evolution of cancer research and drug discovery at Lilly Research Laboratories.Chemotherapy in the elderly: pharmacologic considerations.The role of new agents in advanced non-small-cell lung carcinoma.Pemetrexed (Alimta) and gemcitabine in breast cancer patients previously treated with anthracyclines and taxanes.Gemcitabine in breast cancer: future directions.Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs.The mechanism of action of radiosensitization of conventional chemotherapeutic agents.Preclinical and clinical studies with combinations of pemetrexed and gemcitabine.Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer.Hypersensitivity pneumonitis in advanced non-small-cell lung cancer patients receiving gemcitabine and paclitaxel: report of two cases and a review of the literature.Gemcitabine in metastatic breast cancer.Role of gemcitabine in cancer therapy.Development of gemcitabine in non-small cell lung cancer: the Italian contribution.Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.Treatment of early-stage nonbulky Hodgkin lymphoma.Intravesical gemcitabine: an update of clinical results.Synthesis and biological activity of a gemcitabine phosphoramidate prodrugClinical management of T-cell malignancies: current perspectives, key issues, and emerging therapies.The role of chemotherapy in biliary tract carcinoma.The role of pemetrexed combined with gemcitabine for non-small-cell lung cancer.Pharmacological factors affecting accumulation of gemcitabine's active metabolite, gemcitabine triphosphate.Synergistic effects of acyclic retinoid and gemcitabine on growth inhibition in pancreatic cancer cells.NS-398 enhances the efficacy of gemcitabine against lung adenocarcinoma through up-regulation of p21WAF1 and p27KIP1 protein.Comprehensive study of sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines.Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.Optimization of naphthalimide-imidazoacridone with potent antitumor activity leading to clinical candidate (HKH40A, RTA 502).
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Gemcitabin
@de
Gemcitabin
@sh
Gemcitabin
@sl
Gemcitabin
@sr
Gemcitabina
@es
Gemcitabine
@vi
Gemcitabină
@ro
Gemsitabiini
@fi
Gemsitabin
@id
Gemzitabina
@eu
type
label
Gemcitabin
@de
Gemcitabin
@sh
Gemcitabin
@sl
Gemcitabin
@sr
Gemcitabina
@es
Gemcitabine
@vi
Gemcitabină
@ro
Gemsitabiini
@fi
Gemsitabin
@id
Gemzitabina
@eu
altLabel
122111-03-9
@fr
2',2'-Difluorodeoxycytidine
@en
2'-Deoxy-2',2'-difluorocytidine
@en
2′,2′-difluoro-2′-deoksycytydyna
@pl
4-amino-1-((2R,4R,5R)-3,3-Difl ...... furan-2-yl)pyrimidin-2(1H)-one
@en
4-amino-1-((2R,4R,5R)-3,3-difl ...... furan-2-yl)pyrimidin-2(1H)-one
@cy
4-amino-1-((2R,4R,5R)-3,3-difl ...... furan-2-yl)pyrimidin-2(1H)-one
@en
95058-81-4
@fr
C9H11F2N3O4
@fr
C9H11F2N3O4
@it
prefLabel
Gemcitabin
@de
Gemcitabin
@sh
Gemcitabin
@sl
Gemcitabin
@sr
Gemcitabina
@es
Gemcitabine
@vi
Gemcitabină
@ro
Gemsitabiini
@fi
Gemsitabin
@id
Gemzitabina
@eu